Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-06-29

AUTHORS

J Hara, Y Osugi, H Ohta, Y Matsuda, K Nakanishi, K Takai, H Fujisaki, S Tokimasa, M Fukuzawa, A Okada, S Okada

ABSTRACT

Major dose-limiting factors of high-dose thiotepa (TEPA) and melphalan are life-threatening mucositis and neurotoxicity. To administer a maximum dose of these drugs safely and to obtain a maximum anti-cancer effect, a double-conditioning regimen with a single grafting, two cycles of administration of a combination of TEPA (300–600 mg/m2) plus melphalan (70–150 mg/m2) with a 1-week interval was attempted in 20 patients with pediatric advanced or chemotherapy-resistant solid tumors (seven rhabdomyosarcoma, four hepatoblastoma, three neuroblastoma and four other malignancy). Combinations of TEPA plus melphalan/busulfan (Bu) (8–10 mg/kg) and TEPA plus Bu were given to four and two patients with brain tumors, respectively. In an additional two patients, three cycles of drug administration were performed. According to the results of the dose-escalating study, the maximum tolerable doses of TEPA and melphalan for children aged 2 years old or older were 1000 mg/m2 and 280 mg/m2, respectively. Mucositis was dose-limiting. Renal toxicity was also dose-limiting in young children (<2 years old). there were two treatment-related deaths (7%) (fungal pneumonia and renal tubular acidosis). among 13 patients who received high-dose chemotherapy during cr, 10 are alive with no evidence of disease (15–59 months, median: 35 months) and in 13 evaluable patients without cr, six are alive without regrowth of the disease (14–59 months, median: 39 months). thus, these novel conditioning regimens allowed us to increase the dose intensity to nearly the maximum for each drug and seemed to reduce adverse effects compared to previously reported regimens with these drugs. with regard to the effect on outcome, the results of this study seem to be encouraging, but a further study on a larger number of patients is required. More... »

PAGES

7-12

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bmt.1701283

DOI

http://dx.doi.org/10.1038/sj.bmt.1701283

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1012091956

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9678789


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Agranulocytosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Busulfan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melphalan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thiotepa", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombocytopenia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation Conditioning", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hara", 
        "givenName": "J", 
        "id": "sg:person.01154453452.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154453452.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Osugi", 
        "givenName": "Y", 
        "id": "sg:person.01172100025.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172100025.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohta", 
        "givenName": "H", 
        "id": "sg:person.01152115360.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152115360.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsuda", 
        "givenName": "Y", 
        "id": "sg:person.01322175505.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322175505.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakanishi", 
        "givenName": "K", 
        "id": "sg:person.016573776302.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016573776302.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takai", 
        "givenName": "K", 
        "id": "sg:person.0673307625.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673307625.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fujisaki", 
        "givenName": "H", 
        "id": "sg:person.0772111652.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772111652.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tokimasa", 
        "givenName": "S", 
        "id": "sg:person.01106576551.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106576551.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatric Surgery, Osaka University School of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Pediatric Surgery, Osaka University School of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fukuzawa", 
        "givenName": "M", 
        "id": "sg:person.01176624231.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176624231.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatric Surgery, Osaka University School of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Pediatric Surgery, Osaka University School of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okada", 
        "givenName": "A", 
        "id": "sg:person.0725725344.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725725344.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan", 
          "id": "http://www.grid.ac/institutes/grid.136593.b", 
          "name": [
            "Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okada", 
        "givenName": "S", 
        "id": "sg:person.010007364502.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010007364502.54"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1998-06-29", 
    "datePublishedReg": "1998-06-29", 
    "description": "Major dose-limiting factors of high-dose thiotepa (TEPA) and melphalan are life-threatening mucositis and neurotoxicity. To administer a maximum dose of these drugs safely and to obtain a maximum anti-cancer effect, a double-conditioning regimen with a single grafting, two cycles of administration of a combination of TEPA (300\u2013600\u2009mg/m2) plus melphalan (70\u2013150\u2009mg/m2) with a 1-week interval was attempted in 20 patients with pediatric advanced or chemotherapy-resistant solid tumors (seven rhabdomyosarcoma, four hepatoblastoma, three neuroblastoma and four other malignancy). Combinations of TEPA plus melphalan/busulfan (Bu) (8\u201310\u2009mg/kg) and TEPA plus Bu were given to four and two patients with brain tumors, respectively. In an additional two patients, three cycles of drug administration were performed. According to the results of the dose-escalating study, the maximum tolerable doses of TEPA and melphalan for children aged 2 years old or older were 1000\u2009mg/m2 and 280\u2009mg/m2, respectively. Mucositis was dose-limiting. Renal toxicity was also dose-limiting in young children (<2 years old). there were two treatment-related deaths (7%) (fungal pneumonia and renal tubular acidosis). among 13 patients who received high-dose chemotherapy during cr, 10 are alive with no evidence of disease (15\u201359\u2009months, median: 35 months) and in 13 evaluable patients without cr, six are alive without regrowth of the disease (14\u201359 months, median: 39 months). thus, these novel conditioning regimens allowed us to increase the dose intensity to nearly the maximum for each drug and seemed to reduce adverse effects compared to previously reported regimens with these drugs. with regard to the effect on outcome, the results of this study seem to be encouraging, but a further study on a larger number of patients is required.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bmt.1701283", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "keywords": [
      "combination of thiotepa", 
      "solid tumors", 
      "chemotherapy-resistant solid tumors", 
      "major dose-limiting factor", 
      "high-dose thiotepa", 
      "life-threatening mucositis", 
      "double-conditioning regimen", 
      "dose-escalating study", 
      "treatment-related deaths", 
      "novel conditioning regimens", 
      "stem cell rescue", 
      "high-dose chemotherapy", 
      "evidence of disease", 
      "dose-limiting factor", 
      "cycles of administration", 
      "maximum tolerable doses", 
      "pediatric solid tumors", 
      "anti-cancer effects", 
      "evaluable patients", 
      "conditioning regimens", 
      "dose intensity", 
      "renal toxicity", 
      "tolerable doses", 
      "brain tumors", 
      "thiotepa", 
      "cell rescue", 
      "patients", 
      "Drug Administration", 
      "melphalan", 
      "maximum dose", 
      "regimens", 
      "single grafting", 
      "adverse effects", 
      "tumors", 
      "mucositis", 
      "drugs", 
      "busulfan", 
      "young children", 
      "Further studies", 
      "disease", 
      "administration", 
      "children", 
      "regimen", 
      "chemotherapy", 
      "neurotoxicity", 
      "dose", 
      "doses", 
      "study", 
      "death", 
      "outcomes", 
      "treatment", 
      "effect", 
      "toxicity", 
      "grafting", 
      "m2", 
      "years", 
      "interval", 
      "combination", 
      "evidence", 
      "rescue", 
      "factors", 
      "regrowth", 
      "large number", 
      "results", 
      "regard", 
      "cycle", 
      "number", 
      "Bu", 
      "intensity", 
      "Cr", 
      "maximum", 
      "limiting"
    ], 
    "name": "Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors", 
    "pagination": "7-12", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1012091956"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bmt.1701283"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9678789"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bmt.1701283", 
      "https://app.dimensions.ai/details/publication/pub.1012091956"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:53", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_297.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bmt.1701283"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1701283'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1701283'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1701283'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1701283'


 

This table displays all metadata directly associated to this object as RDF triples.

265 TRIPLES      20 PREDICATES      112 URIs      104 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bmt.1701283 schema:about N0a708d4b858741759eed0fa998b347d8
2 N0ea34b155f094a18b5aa5c5428c9f762
3 N1cce7361e461445d9b4831a60e380baa
4 N28cdf779dba647a6b05ad839c4867edb
5 N4d6283b83d66451d80cb7da19089e4d1
6 N605fddb9058d41b6aa88358def6f6469
7 N6205b4fa9d794cc380303941c8f0c12d
8 N9248df7879644996b89ea325731b0136
9 Nab73f90e480f409c91ac8bfd7336b852
10 Nba785fdfaf7e4d3794f706bd0dbf4a97
11 Nd30f6890360a4b1194e437c96f1d2076
12 Nd58224ca7eb747e4a08167a889ac5b78
13 Nd6f364d6eeef4f63927d67ffbf2560b1
14 Ne172df3f8ed643618849d08ae4433154
15 Nf8c7467f8b5a4c74849122220ab8dd88
16 anzsrc-for:11
17 anzsrc-for:1112
18 schema:author N868f75762c3f40baac71a42bd9efef5a
19 schema:datePublished 1998-06-29
20 schema:datePublishedReg 1998-06-29
21 schema:description Major dose-limiting factors of high-dose thiotepa (TEPA) and melphalan are life-threatening mucositis and neurotoxicity. To administer a maximum dose of these drugs safely and to obtain a maximum anti-cancer effect, a double-conditioning regimen with a single grafting, two cycles of administration of a combination of TEPA (300–600 mg/m2) plus melphalan (70–150 mg/m2) with a 1-week interval was attempted in 20 patients with pediatric advanced or chemotherapy-resistant solid tumors (seven rhabdomyosarcoma, four hepatoblastoma, three neuroblastoma and four other malignancy). Combinations of TEPA plus melphalan/busulfan (Bu) (8–10 mg/kg) and TEPA plus Bu were given to four and two patients with brain tumors, respectively. In an additional two patients, three cycles of drug administration were performed. According to the results of the dose-escalating study, the maximum tolerable doses of TEPA and melphalan for children aged 2 years old or older were 1000 mg/m2 and 280 mg/m2, respectively. Mucositis was dose-limiting. Renal toxicity was also dose-limiting in young children (<2 years old). there were two treatment-related deaths (7%) (fungal pneumonia and renal tubular acidosis). among 13 patients who received high-dose chemotherapy during cr, 10 are alive with no evidence of disease (15–59 months, median: 35 months) and in 13 evaluable patients without cr, six are alive without regrowth of the disease (14–59 months, median: 39 months). thus, these novel conditioning regimens allowed us to increase the dose intensity to nearly the maximum for each drug and seemed to reduce adverse effects compared to previously reported regimens with these drugs. with regard to the effect on outcome, the results of this study seem to be encouraging, but a further study on a larger number of patients is required.
22 schema:genre article
23 schema:isAccessibleForFree false
24 schema:isPartOf N1e534447fb9a436ea38f0db1180d11f6
25 Nad1af56f0079460082fbd22a2a7cd8c3
26 sg:journal.1096890
27 schema:keywords Bu
28 Cr
29 Drug Administration
30 Further studies
31 administration
32 adverse effects
33 anti-cancer effects
34 brain tumors
35 busulfan
36 cell rescue
37 chemotherapy
38 chemotherapy-resistant solid tumors
39 children
40 combination
41 combination of thiotepa
42 conditioning regimens
43 cycle
44 cycles of administration
45 death
46 disease
47 dose
48 dose intensity
49 dose-escalating study
50 dose-limiting factor
51 doses
52 double-conditioning regimen
53 drugs
54 effect
55 evaluable patients
56 evidence
57 evidence of disease
58 factors
59 grafting
60 high-dose chemotherapy
61 high-dose thiotepa
62 intensity
63 interval
64 large number
65 life-threatening mucositis
66 limiting
67 m2
68 major dose-limiting factor
69 maximum
70 maximum dose
71 maximum tolerable doses
72 melphalan
73 mucositis
74 neurotoxicity
75 novel conditioning regimens
76 number
77 outcomes
78 patients
79 pediatric solid tumors
80 regard
81 regimen
82 regimens
83 regrowth
84 renal toxicity
85 rescue
86 results
87 single grafting
88 solid tumors
89 stem cell rescue
90 study
91 thiotepa
92 tolerable doses
93 toxicity
94 treatment
95 treatment-related deaths
96 tumors
97 years
98 young children
99 schema:name Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors
100 schema:pagination 7-12
101 schema:productId N20b442326dc04650b53364ce1730b031
102 N90d789a97641466c9ef0fd6c01ba6250
103 Nd74fbf961d3b4b94b952ac3a9e1cea42
104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012091956
105 https://doi.org/10.1038/sj.bmt.1701283
106 schema:sdDatePublished 2022-08-04T16:53
107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
108 schema:sdPublisher N75fc40012da842a299186ec3f30fb55d
109 schema:url https://doi.org/10.1038/sj.bmt.1701283
110 sgo:license sg:explorer/license/
111 sgo:sdDataset articles
112 rdf:type schema:ScholarlyArticle
113 N0a708d4b858741759eed0fa998b347d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Hematopoietic Stem Cell Transplantation
115 rdf:type schema:DefinedTerm
116 N0ea34b155f094a18b5aa5c5428c9f762 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Child, Preschool
118 rdf:type schema:DefinedTerm
119 N1cce7361e461445d9b4831a60e380baa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Humans
121 rdf:type schema:DefinedTerm
122 N1e534447fb9a436ea38f0db1180d11f6 schema:issueNumber 1
123 rdf:type schema:PublicationIssue
124 N1f4095473f4c45448efea0010680872c rdf:first sg:person.01106576551.49
125 rdf:rest N809a0a1cdd914c80afa043d88a195b85
126 N20b442326dc04650b53364ce1730b031 schema:name pubmed_id
127 schema:value 9678789
128 rdf:type schema:PropertyValue
129 N28cdf779dba647a6b05ad839c4867edb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Antineoplastic Combined Chemotherapy Protocols
131 rdf:type schema:DefinedTerm
132 N4d6283b83d66451d80cb7da19089e4d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Adolescent
134 rdf:type schema:DefinedTerm
135 N5196421b28684bbf9119f0b31aee654a rdf:first sg:person.0772111652.27
136 rdf:rest N1f4095473f4c45448efea0010680872c
137 N5367f8e9d0704228a29a724c66609eab rdf:first sg:person.01172100025.27
138 rdf:rest Nb2a756711f91494aad68a27e45c5f346
139 N605fddb9058d41b6aa88358def6f6469 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Neoplasms
141 rdf:type schema:DefinedTerm
142 N6205b4fa9d794cc380303941c8f0c12d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Thiotepa
144 rdf:type schema:DefinedTerm
145 N6363f44ca17a4788a5fd678204321a2e rdf:first sg:person.0725725344.49
146 rdf:rest N8dcc6250a62e491a90a8a1029b555d13
147 N75fc40012da842a299186ec3f30fb55d schema:name Springer Nature - SN SciGraph project
148 rdf:type schema:Organization
149 N809a0a1cdd914c80afa043d88a195b85 rdf:first sg:person.01176624231.59
150 rdf:rest N6363f44ca17a4788a5fd678204321a2e
151 N868f75762c3f40baac71a42bd9efef5a rdf:first sg:person.01154453452.69
152 rdf:rest N5367f8e9d0704228a29a724c66609eab
153 N8dcc6250a62e491a90a8a1029b555d13 rdf:first sg:person.010007364502.54
154 rdf:rest rdf:nil
155 N90d789a97641466c9ef0fd6c01ba6250 schema:name doi
156 schema:value 10.1038/sj.bmt.1701283
157 rdf:type schema:PropertyValue
158 N9248df7879644996b89ea325731b0136 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Thrombocytopenia
160 rdf:type schema:DefinedTerm
161 Na183ee3f19304db9b39a3f68bbeb9db7 rdf:first sg:person.016573776302.21
162 rdf:rest Nf275b6d3bd3045c690a03154f9c12c3e
163 Nab73f90e480f409c91ac8bfd7336b852 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Adult
165 rdf:type schema:DefinedTerm
166 Nad1af56f0079460082fbd22a2a7cd8c3 schema:volumeNumber 22
167 rdf:type schema:PublicationVolume
168 Nb2a756711f91494aad68a27e45c5f346 rdf:first sg:person.01152115360.23
169 rdf:rest Nf84f37f2a562450aa20c3f3ab3106cee
170 Nba785fdfaf7e4d3794f706bd0dbf4a97 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Melphalan
172 rdf:type schema:DefinedTerm
173 Nd30f6890360a4b1194e437c96f1d2076 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Transplantation Conditioning
175 rdf:type schema:DefinedTerm
176 Nd58224ca7eb747e4a08167a889ac5b78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Child
178 rdf:type schema:DefinedTerm
179 Nd6f364d6eeef4f63927d67ffbf2560b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Infant
181 rdf:type schema:DefinedTerm
182 Nd74fbf961d3b4b94b952ac3a9e1cea42 schema:name dimensions_id
183 schema:value pub.1012091956
184 rdf:type schema:PropertyValue
185 Ne172df3f8ed643618849d08ae4433154 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Agranulocytosis
187 rdf:type schema:DefinedTerm
188 Nf275b6d3bd3045c690a03154f9c12c3e rdf:first sg:person.0673307625.97
189 rdf:rest N5196421b28684bbf9119f0b31aee654a
190 Nf84f37f2a562450aa20c3f3ab3106cee rdf:first sg:person.01322175505.03
191 rdf:rest Na183ee3f19304db9b39a3f68bbeb9db7
192 Nf8c7467f8b5a4c74849122220ab8dd88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Busulfan
194 rdf:type schema:DefinedTerm
195 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
196 schema:name Medical and Health Sciences
197 rdf:type schema:DefinedTerm
198 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
199 schema:name Oncology and Carcinogenesis
200 rdf:type schema:DefinedTerm
201 sg:journal.1096890 schema:issn 0268-3369
202 1476-5365
203 schema:name Bone Marrow Transplantation
204 schema:publisher Springer Nature
205 rdf:type schema:Periodical
206 sg:person.010007364502.54 schema:affiliation grid-institutes:grid.136593.b
207 schema:familyName Okada
208 schema:givenName S
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010007364502.54
210 rdf:type schema:Person
211 sg:person.01106576551.49 schema:affiliation grid-institutes:grid.136593.b
212 schema:familyName Tokimasa
213 schema:givenName S
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106576551.49
215 rdf:type schema:Person
216 sg:person.01152115360.23 schema:affiliation grid-institutes:grid.136593.b
217 schema:familyName Ohta
218 schema:givenName H
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152115360.23
220 rdf:type schema:Person
221 sg:person.01154453452.69 schema:affiliation grid-institutes:grid.136593.b
222 schema:familyName Hara
223 schema:givenName J
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154453452.69
225 rdf:type schema:Person
226 sg:person.01172100025.27 schema:affiliation grid-institutes:grid.136593.b
227 schema:familyName Osugi
228 schema:givenName Y
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01172100025.27
230 rdf:type schema:Person
231 sg:person.01176624231.59 schema:affiliation grid-institutes:grid.136593.b
232 schema:familyName Fukuzawa
233 schema:givenName M
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176624231.59
235 rdf:type schema:Person
236 sg:person.01322175505.03 schema:affiliation grid-institutes:grid.136593.b
237 schema:familyName Matsuda
238 schema:givenName Y
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322175505.03
240 rdf:type schema:Person
241 sg:person.016573776302.21 schema:affiliation grid-institutes:grid.136593.b
242 schema:familyName Nakanishi
243 schema:givenName K
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016573776302.21
245 rdf:type schema:Person
246 sg:person.0673307625.97 schema:affiliation grid-institutes:grid.136593.b
247 schema:familyName Takai
248 schema:givenName K
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673307625.97
250 rdf:type schema:Person
251 sg:person.0725725344.49 schema:affiliation grid-institutes:grid.136593.b
252 schema:familyName Okada
253 schema:givenName A
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725725344.49
255 rdf:type schema:Person
256 sg:person.0772111652.27 schema:affiliation grid-institutes:grid.136593.b
257 schema:familyName Fujisaki
258 schema:givenName H
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772111652.27
260 rdf:type schema:Person
261 grid-institutes:grid.136593.b schema:alternateName Department of Pediatric Surgery, Osaka University School of Medicine, Osaka, Japan
262 Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan
263 schema:name Department of Pediatric Surgery, Osaka University School of Medicine, Osaka, Japan
264 Department of Pediatrics, Osaka University School of Medicine, Osaka, Japan
265 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...